
BDSI’s cancer pain treatment Onsolis now slated for 3Q Canada launch
BioDelivery Sciences International‘s (NASDAQ:BDSI) treatment for breakthrough cancer pain is now slated to launch in Canada this quarter – more than a year after the company had initially planned its Canada launch. Raleigh, North Carolina-based BDSI received Health Canada approval for Onsolis in May 2010, which put the product on a track for a Canada […]